European equities traded in the US as American depositary receipts were moving lower late Friday morning, declining 0.85% to 1,302.64 on the S&P Europe Select ADR Index, which is down about 2.8% for the week.
From continental Europe, the gainers were led by financial services company Banco Bilbao Vizcaya Argentaria (BBVA) and pharmaceutical company Ascendis Pharma (ASND), which rose 3.2% and 2.7%, respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and financial services company Banco Santander (SAN), which increased 2.3% and 2.2%, respectively.
The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company Cellectis (CLLS), which fell 9.3% and 6.8%, respectively. They were followed by biotech firm BioNTech (BNTX) and biopharmaceutical company argenx (ARGX), which lost 6.2% and 4.5%, respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company TC Biopharm (TCBP) and financial services company Lloyds Banking Group (LYG), which advanced 16% and 2%, respectively. They were followed by tobacco company British American Tobacco (BTI) and insurance company Prudential (PUK), which were up 1.9% and 1.5%, respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Biodexa Pharmaceuticals (BDRX), which tumbled 20% and 12%, respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group (MREO) and Bicycle Therapeutics (BCYC), which dropped 5.7% and 5.5%, respectively.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。